| Product Code: ETC6744021 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Genomic Medicine Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Genomic Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 China Genomic Medicine Market - Industry Life Cycle |
3.4 China Genomic Medicine Market - Porter's Five Forces |
3.5 China Genomic Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 China Genomic Medicine Market Revenues & Volume Share, By End- User, 2021 & 2031F |
4 China Genomic Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government support and investment in genomic medicine research and development in China |
4.2.2 Rising prevalence of genetic disorders and chronic diseases driving the demand for genomic medicine solutions |
4.2.3 Growing awareness and adoption of personalized medicine approaches in healthcare |
4.2.4 Technological advancements in genomics leading to more efficient and cost-effective genomic medicine solutions |
4.3 Market Restraints |
4.3.1 High costs associated with genomic medicine technologies and treatments limiting accessibility for a large portion of the population |
4.3.2 Lack of skilled professionals and infrastructure for genomic medicine implementation and interpretation |
4.3.3 Regulatory challenges and ethical considerations surrounding genetic data privacy and use |
5 China Genomic Medicine Market Trends |
6 China Genomic Medicine Market, By Types |
6.1 China Genomic Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 China Genomic Medicine Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 China Genomic Medicine Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 China Genomic Medicine Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.1.5 China Genomic Medicine Market Revenues & Volume, By Paediatrics, 2021- 2031F |
6.1.6 China Genomic Medicine Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.1.7 China Genomic Medicine Market Revenues & Volume, By Respiratory Medicine, 2021- 2031F |
6.1.8 China Genomic Medicine Market Revenues & Volume, By Rare Genetic Disorders, 2021- 2031F |
6.1.9 China Genomic Medicine Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 China Genomic Medicine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Genomic Medicine Market, By End- User |
6.2.1 Overview and Analysis |
6.2.2 China Genomic Medicine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 China Genomic Medicine Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 China Genomic Medicine Market Revenues & Volume, By Academic Institutions, 2021- 2031F |
6.2.5 China Genomic Medicine Market Revenues & Volume, By Research Institutions, 2021- 2031F |
7 China Genomic Medicine Market Import-Export Trade Statistics |
7.1 China Genomic Medicine Market Export to Major Countries |
7.2 China Genomic Medicine Market Imports from Major Countries |
8 China Genomic Medicine Market Key Performance Indicators |
8.1 Number of research grants and funding allocated by the Chinese government for genomic medicine projects |
8.2 Percentage increase in genetic testing and sequencing services uptake in China |
8.3 Number of partnerships and collaborations between Chinese genomic medicine companies and international organizations for knowledge exchange and technology transfer |
8.4 Rate of adoption of genomic medicine guidelines and protocols by healthcare institutions in China |
8.5 Improvement in patient outcomes and healthcare efficiency metrics attributed to the integration of genomic medicine practices |
9 China Genomic Medicine Market - Opportunity Assessment |
9.1 China Genomic Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 China Genomic Medicine Market Opportunity Assessment, By End- User, 2021 & 2031F |
10 China Genomic Medicine Market - Competitive Landscape |
10.1 China Genomic Medicine Market Revenue Share, By Companies, 2024 |
10.2 China Genomic Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here